These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1331933)

  • 21. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
    Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
    Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
    Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
    Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
    Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
    Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
    Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
    J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome.
    Santos A; Osorio-Almeida L; Baird PN; Silva JM; Boavida MG; Cowell J
    Hum Genet; 1993 Aug; 92(1):83-6. PubMed ID: 8396067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing.
    Hogg A; Onadim Z; Baird PN; Cowell JK
    Oncogene; 1992 Jul; 7(7):1445-51. PubMed ID: 1352398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
    Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
    Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient.
    Pritchard-Jones K; Renshaw J; King-Underwood L
    Hum Mol Genet; 1994 Sep; 3(9):1633-7. PubMed ID: 7833922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
    Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
    Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A clinical overview of WT1 gene mutations.
    Little M; Wells C
    Hum Mutat; 1997; 9(3):209-25. PubMed ID: 9090524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular evidence of the independent origin of multiple Wilms tumors in a case of WAGR syndrome.
    Uccini S; Perotti D; Colarossi C; Stoppacciaro A; Sardella M; Mannarino O; Collini P; Casieri P; Cozzi D; Amoroso L; Spreafico F; Radice P; Dominici C
    Pediatr Blood Cancer; 2008 Sep; 51(3):344-8. PubMed ID: 18293378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
    Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
    J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
    Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
    Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The candidate Wilms' tumour gene is involved in genitourinary development.
    Pritchard-Jones K; Fleming S; Davidson D; Bickmore W; Porteous D; Gosden C; Bard J; Buckler A; Pelletier J; Housman D
    Nature; 1990 Jul; 346(6280):194-7. PubMed ID: 2164159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor].
    Jiang YP; Shen Y; Sun N; Wang H
    Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.